Items where Author is "Bakherad, H."

Article

(2025) Synthesis, QSAR modeling, and molecular docking studies of 1,2,3-triazo-le-pyrazole hybrids as significant anti-cancer and anti-microbial agents. Journal of Molecular Structure. p. 15. ISSN 0022-2860

(2024) Covid-19 Prevention and Treatment by Targeting Fc-fusion Proteins: An Experience to Fight Emerging Diseases. Current Molecular Medicine. pp. 428-434. ISSN 1566-5240

(2024) In silico designing and optimization of anti-epidermal growth factor receptor scaffolds by complementary-determining regions-grafting technique. Quantitative Biology. pp. 301-312. ISSN 2095-4689

(2024) Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model. Bioimpacts. p. 9. ISSN 2228-5652

(2024) Investigating the effect of cGRP78 vaccine against different cancer cells and its role in reducing melanoma metastasis. Research in Pharmaceutical Sciences. pp. 73-82. ISSN 1735-5362

(2024) Synthesis, and molecular docking studies of novel 1,2,3-triazoles-linked pyrazole carboxamides as significant anti-microbial and anti-cancer agents. Results in Chemistry. p. 17. ISSN 2211-7156

(2023) Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model. Scientific Reports. p. 15. ISSN 2045-2322

(2023) Biochemical and molecular characterization of novel keratinolytic protease from <i>Bacillus licheniformis</i> (KRLr1). Frontiers in Microbiology. p. 24.

(2023) Production of Recombinant E.coli Asparaginase on a Laboratory Scale. Journal of Isfahan Medical School. pp. 950-956. ISSN 10277595 (ISSN)

(2023) Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole-Tetrahydropyrimidinone(thione) Hybrid Scaffolds as Urease Inhibitors. Chemistry & Biodiversity. p. 14. ISSN 1612-1872

(2023) Synthesis, biological assessment, and computational investigations of nifedipine and monastrol analogues as anti-leishmanial major and anti-microbial agents. Molecular Diversity. pp. 2555-2575. ISSN 1573-501X (Electronic) 1381-1991 (Linking)

(2023) A novel approach to enhance the performance of kallikrein 6 enzyme using <i>Pichia pastoris</i> GS115 as a host. Research in Pharmaceutical Sciences. pp. 541-550. ISSN 1735-5362

(2022) Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors. Arch Pharm (Weinheim). e2200158. ISSN 0365-6233

(2022) In silico and in vitro studies of thiosemicarbazone-indole hybrid compounds as potent alpha-glycosidase inhibitors. COMPUTATIONAL BIOLOGY AND CHEMISTRY. ISSN 1476-9271 1476-928X J9 - COMPUT BIOL CHEM

(2022) In silico and in vitro studies of thiosemicarbazone-indole hybrid compounds as potent α-glycosidase inhibitors. Computational Biology and Chemistry. ISSN 14769271 (ISSN)

(2022) Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer. CANCER CELL INTERNATIONAL. ISSN 1475-2867 J9 - CANCER CELL INT

(2022) Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review. Analytical biochemistry. p. 114546. ISSN 1096-0309 (Electronic) 0003-2697 (Print) 0003-2697 (Linking)

(2022) Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review. ANALYTICAL BIOCHEMISTRY. ISSN 0003-2697 1096-0309 J9 - ANAL BIOCHEM

(2021) Nanobodies, the potent agents to detect and treat the Coronavirus infections: A systematic review. Molecular and Cellular Probes. ISSN 0890-8508

(2021) Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer. CANCER CELL INTERNATIONAL. ISSN 1475-2867 J9 - CANCER CELL INT